328 related articles for article (PubMed ID: 38240572)
1. VesiX cetylpyridinium chloride is rapidly bactericidal and reduces uropathogenic
Sawant NV; Chang SS; Pandit KA; Khekare P; Warner WR; Zimmern PE; De Nisco NJ
Microbiol Spectr; 2024 Mar; 12(3):e0271223. PubMed ID: 38240572
[TBL] [Abstract][Full Text] [Related]
2. Plant phenolics inhibit focal adhesion kinase and suppress host cell invasion by uropathogenic
Lewis AJ; Richards AC; Mendez AA; Dhakal BK; Jones TA; Sundsbak JL; Eto DS; Rousek AA; Mulvey MA
Infect Immun; 2024 May; 92(5):e0008024. PubMed ID: 38534100
[TBL] [Abstract][Full Text] [Related]
3. Urinary Tract Infections Caused by Uropathogenic
Zhou Y; Zhou Z; Zheng L; Gong Z; Li Y; Jin Y; Huang Y; Chi M
Int J Mol Sci; 2023 Jun; 24(13):. PubMed ID: 37445714
[TBL] [Abstract][Full Text] [Related]
4. Neomycin-polymyxin or gentamicin bladder instillations decrease symptomatic urinary tract infections in neurogenic bladder patients on clean intermittent catheterization.
Huen KH; Nik-Ahd F; Chen L; Lerman S; Singer J
J Pediatr Urol; 2019 Apr; 15(2):178.e1-178.e7. PubMed ID: 30611650
[TBL] [Abstract][Full Text] [Related]
5. Uropathogenic
Li ZP; Li J; Li TL; Song ZY; Gong XZ
Front Cell Infect Microbiol; 2024; 14():1322119. PubMed ID: 38638825
[TBL] [Abstract][Full Text] [Related]
6. Photochemical inactivation as an alternative method to produce a whole-cell vaccine for uropathogenic
Westcott MM; Morse AE; Troy G; Blevins M; Wierzba T; Sanders JW
Microbiol Spectr; 2024 Mar; 12(3):e0366123. PubMed ID: 38315025
[TBL] [Abstract][Full Text] [Related]
7. Intravesical gentamicin instillation in the prevention of recurrent urinary tract infections in children with neurogenic bladder- a single-center retrospective observational study.
Mouhssine M; Al Ani D; Al Shibli A; Ghatasheh G; Al Amri A; Matta H; Chedid R; Narchi H
J Pediatr Urol; 2023 Feb; 19(1):64.e1-64.e7. PubMed ID: 36216695
[TBL] [Abstract][Full Text] [Related]
8. Phage Resistance Accompanies Reduced Fitness of Uropathogenic Escherichia coli in the Urinary Environment.
Zulk JJ; Clark JR; Ottinger S; Ballard MB; Mejia ME; Mercado-Evans V; Heckmann ER; Sanchez BC; Trautner BW; Maresso AW; Patras KA
mSphere; 2022 Aug; 7(4):e0034522. PubMed ID: 35920561
[TBL] [Abstract][Full Text] [Related]
9. Reaching the End of the Line: Urinary Tract Infections.
Tamadonfar KO; Omattage NS; Spaulding CN; Hultgren SJ
Microbiol Spectr; 2019 May; 7(3):. PubMed ID: 31172909
[TBL] [Abstract][Full Text] [Related]
10. Ribonuclease 7 Shields the Kidney and Bladder from Invasive Uropathogenic
Eichler T; Bender K; Murtha MJ; Schwartz L; Metheny J; Solden L; Jaggers RM; Bailey MT; Gupta S; Mosquera C; Ching C; La Perle K; Li B; Becknell B; Spencer JD
J Am Soc Nephrol; 2019 Aug; 30(8):1385-1397. PubMed ID: 31239387
[TBL] [Abstract][Full Text] [Related]
11. Oral supplementation of trans-cinnamaldehyde reduces uropathogenic Escherichia coli colonization in a mouse model.
Narayanan A; Muyyarikkandy MS; Mooyottu S; Venkitanarayanan K; Amalaradjou MA
Lett Appl Microbiol; 2017 Mar; 64(3):192-197. PubMed ID: 28063174
[TBL] [Abstract][Full Text] [Related]
12. Secretory leukocyte protease inhibitor protects against severe urinary tract infection in mice.
Rosen AL; Lint MA; Voelker DH; Gilbert NM; Tomera CP; Santiago-Borges J; Wallace MA; Hannan TJ; Burnham C-AD; Hultgren SJ; Kau AL
mBio; 2024 Feb; 15(2):e0255423. PubMed ID: 38270443
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of prevalence, immunogenicity and efficacy of FyuA iron receptor in uropathogenic Escherichia coli isolates as a vaccine target against urinary tract infection.
Habibi M; Asadi Karam MR; Bouzari S
Microb Pathog; 2017 Sep; 110():477-483. PubMed ID: 28754265
[TBL] [Abstract][Full Text] [Related]
14. Kinetics of uropathogenic Escherichia coli metapopulation movement during urinary tract infection.
Walters MS; Lane MC; Vigil PD; Smith SN; Walk ST; Mobley HL
mBio; 2012; 3(1):. PubMed ID: 22318320
[TBL] [Abstract][Full Text] [Related]
15. Metabolic Requirements of Escherichia coli in Intracellular Bacterial Communities during Urinary Tract Infection Pathogenesis.
Conover MS; Hadjifrangiskou M; Palermo JJ; Hibbing ME; Dodson KW; Hultgren SJ
mBio; 2016 Apr; 7(2):e00104-16. PubMed ID: 27073089
[TBL] [Abstract][Full Text] [Related]
16. Intracellular uropathogenic Escherichia coli are undetectable in urinary bladders after oral mecillinam treatment: An experimental study in a pig model of cystitis.
Stærk K; Grønnemose RB; Palarasah Y; Lund L; Andersen TE
Microb Pathog; 2022 Dec; 173(Pt A):105817. PubMed ID: 36244593
[TBL] [Abstract][Full Text] [Related]
17. Characterization of host and escherichia coli strains causing recurrent urinary tract infections based on molecular typing.
Kao CY; Zhang YZ; Yang DC; Chen PK; Teng CH; Lin WH; Wang MC
BMC Microbiol; 2023 Mar; 23(1):90. PubMed ID: 36997841
[TBL] [Abstract][Full Text] [Related]
18. Exosomes derived from bladder epithelial cells infected with uropathogenic Escherichia coli increase the severity of urinary tract infections (UTIs) by impairing macrophage function.
Wang Z; Jiang Z; Zhang Y; Wang C; Liu Z; Jia Z; Bhushan S; Yang J; Zhang Z
PLoS Pathog; 2024 Jan; 20(1):e1011926. PubMed ID: 38190378
[TBL] [Abstract][Full Text] [Related]
19. Bacterial characteristics of importance for recurrent urinary tract infections caused by Escherichia coli.
Ejrnæs K
Dan Med Bull; 2011 Apr; 58(4):B4187. PubMed ID: 21466767
[TBL] [Abstract][Full Text] [Related]
20. Phylogenetic group distributions, virulence factors and antimicrobial resistance properties of uropathogenic Escherichia coli strains isolated from patients with urinary tract infections in South Korea.
Lee JH; Subhadra B; Son YJ; Kim DH; Park HS; Kim JM; Koo SH; Oh MH; Kim HJ; Choi CH
Lett Appl Microbiol; 2016 Jan; 62(1):84-90. PubMed ID: 26518617
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
